Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Entity) (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 834.66 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.07 Bn | 5.54 Bn | 220.03 Mn | 156.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.98 Mn |
| Mar 31, 2026 | 76.69 Mn |
| Dec 31, 2025 | 76.29 Mn |
| Sep 30, 2025 | 75.42 Mn |
| Jun 30, 2025 | 74.03 Mn |
| Mar 31, 2025 | 72.80 Mn |
| Dec 31, 2024 | 72.52 Mn |
| Sep 30, 2024 | 72.16 Mn |
| Jun 30, 2024 | 71.08 Mn |
| Mar 31, 2024 | 70.82 Mn |
| Dec 31, 2023 | 70.46 Mn |
| Sep 30, 2023 | 70.32 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Mar 31, 2023 | 69.83 Mn |
| Dec 31, 2022 | 69.70 Mn |
| Sep 30, 2022 | 69.52 Mn |
| Jun 30, 2022 | 69.43 Mn |
| Mar 31, 2022 | 69.27 Mn |
| Dec 31, 2021 | 69.06 Mn |
| Sep 30, 2021 | 68.89 Mn |